Pmgc Holdings Inc. cash flow statement

In fiscal 2025, Pmgc Holdings Inc.'s operations generated −$5.9m of cash; it spent $442,255 on capital projects, leaving free cash flow of −$6.4m.

Cash flow statement

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Pmgc Holdings Inc.: cash flow statement, annual
Fiscal year	2022Dec 2022	2023Dec 2023	2025Dec 2025	LTMJun 2026
Cash from operations	−1,586	−4,557	−5,934	−8,208
Depreciation and amortisation	7	12	96	536
Stock-based pay	172	488	−19	207
Capital spending	—	11	442	0
Free cash flow	—	−4,568	−6,376	−8,208
Free cash flow after stock pay	—	−5,056	−6,357	−8,414
Shares issued	—	1,464	—	—

US$ thousands unless shown otherwise. Fiscal quarters.

Pmgc Holdings Inc.: cash flow statement, quarterly
Quarter	2023 Q4Dec 2023	2024 Q1Mar 2024	2024 Q2Jun 2024	2024 Q3Sept 2024	2025 Q3Sept 2025	2025 Q4Dec 2025	2026 Q1Mar 2026	2026 Q2Jun 2026
Cash from operations	−2,388	−2,324	−781	−382	−1,490	−1,750	−2,980	−1,988
Depreciation and amortisation	4	18	0	0	35	60	159	281
Stock-based pay	141	55	−45	47	13	11	8	175
Capital spending	0	9	0	0	—	347	363	−28
Free cash flow	−2,388	−2,333	−781	−382	—	−2,097	−3,343	−1,960
Free cash flow after stock pay	−2,529	−2,389	−736	−429	—	−2,107	−3,351	−2,135
Shares issued	−0	—	—	—	—	—	—	—

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: ELAB vs VTGN ELAB vs KRRO CLGN vs ELAB

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Pmgc Holdings Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Pmgc Holdings Inc.